发明名称 Assay for Identification of Therapeutics Targeting Ternary Complex Formation in Protein Synthesis
摘要 The present invention provides a novel assay that allows high-throughput screening of chemical compounds for the inhibition of binding between EF-Tu and tRNA.
申请公布号 US2015118678(A1) 申请公布日期 2015.04.30
申请号 US201414529618 申请日期 2014.10.31
申请人 Rutgers, The State University of New Jersey 发明人 Mandecki Wlodek;Goldman Emanuel;Chudaev Maxim
分类号 C12Q1/34;C12Q1/18;G01N33/58;C12N9/14 主分类号 C12Q1/34
代理机构 代理人
主权项 1. A method of identifying whether a test compound possesses antimicrobial activity, said method comprising: a) mixing an elongation factor Tu (EF-Tu) with GTP and an aminoacylated transfer RNA (aa-tRNA) in the presence of said test compound, wherein said EF-Tu is operably linked to a first energy transfer pair member, wherein said aa-tRNA is operably linked to a second energy transfer pair member, and wherein said first energy transfer pair member and said second energy transfer pair member form a fluorescence resonance energy transfer pair; and b) detecting the fluorescence emitted, wherein the level of fluorescence in the presence of the test compound is compared to the level of fluorescence in the absence of the test compound or the level of fluorescence in the presence of a control compound, wherein a difference in fluorescence indicates that the test compound possesses antimicrobial activity.
地址 New Brunswick NJ US